Airway epithelial cell plasma membrane lipid bilayer

The airway epithelial cell plasma membrane lipid bilayer is the fundamental structural component of the cells lining the respiratory tract, providing a selective barrier between the internal cellular environment and the external airway. Composed of a diverse array of phospholipids, sphingolipids, and cholesterol, this bilayer maintains the structural integrity of the epithelium and facilitates essential processes such as ion transport, signal transduction, and vesicle trafficking (Source: NIH, PubMed). In diseases like cystic fibrosis and asthma, alterations in membrane lipid composition can impair the function of transmembrane proteins and exacerbate inflammation (Source: Journal of Lipid Research). This structure is a critical site for the entry of respiratory viruses, which often exploit specific lipid domains, such as lipid rafts, for fusion and internalization (Source: Nature Reviews Microbiology). Therapeutically, the lipid bilayer is targeted by exogenous pulmonary surfactants to treat respiratory distress syndrome and serves as the primary interface for inhaled drug delivery systems, including liposomes and solid lipid nanoparticles (Source: StatPearls). It also plays a role in the pharmacokinetics of inhaled medications, as the lipid composition determines the rate of passive diffusion across the epithelial barrier. Safety concerns associated with targeting this membrane include potential disruption of normal barrier function and the induction of localized inflammatory responses. Understanding the biophysical properties of this bilayer is essential for developing effective aerosolized therapies and preventing pathogen attachment.

Other names

Airway epithelial membraneBronchial epithelial lipid bilayerRespiratory epithelial plasma membrane

Reduction of surface tension, stabilization of the air-liquid interface, and modulation of membrane fluidity to facilitate drug delivery or inhibit viral entry.